Search

Your search keyword '"Friebel, Tara"' showing total 195 results

Search Constraints

Start Over You searched for: Author "Friebel, Tara" Remove constraint Author: "Friebel, Tara"
195 results on '"Friebel, Tara"'

Search Results

1. BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

2. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

3. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

4. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.

5. Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

6. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

7. Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

8. Data from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

9. Supplementary Table 4 from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

10. Supplementary Table 2 from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

11. Supplementary Table 2: Revised 7-14-09 from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

12. Supplementary Table 3 from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

13. Supplementary Table 1 from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

14. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

15. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

16. Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer

17. Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

18. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

20. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

21. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

22. Bilateral Prophylactic Oophorectomy and Bilateral Prophylactic Mastectomy in a Prospective Cohort of Unaffected BRCA1 and BRCA2 Mutation Carriers

23. Abstract PS7-02: The relationship of established breast cancer risk factors with breast cancer subtypes

26. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

28. Validity of Models for Predicting BRCA1 and BRCA2 Mutations

29. Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample

30. Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

32. The FANCM :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

34. The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

35. BRCA1andBRCA2pathogenic sequence variants in women of African origin or ancestry

36. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

37. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

38. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

39. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

40. Additional file 1: Table S1. of Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

41. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

42. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

43. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

44. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

45. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

46. Mutational spectrum in a worldwide study of 29,700 families with <italic>BRCA1</italic> or <italic>BRCA2</italic> mutations.

47. Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations (BRCA+): A multicenter, prospective study.

48. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

49. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

50. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

Catalog

Books, media, physical & digital resources